Melatonin: What the Evidence Actually Supports

Does melatonin actually work for insomnia?

It depends on which sleep problem you mean. For circadian problems — jet lag, a body clock running late, some shift-work schedules — melatonin has a genuine, if modest, role and can shift sleep to a better time. For classic chronic insomnia, where a person lies awake despite being tired at a normal bedtime, the evidence is weak. A national health-agency review found melatonin may modestly shorten how long it takes to fall asleep but concluded there is not enough strong evidence to recommend it for chronic insomnia 1Ref 1National Center for Complementary and Integrative Health (2022).Melatonin: What You Need To Know.NCCIH evidence summary: melatonin has a role in jet lag and delayed sleep-wake phase disorder and may modestly shorten sleep-onset latency, but per AASM and ACP there is not enough strong evidence to recommend it for chronic insomnia — supporting both the circadian-role and weak-for-insomnia claims..

Melatonin treats a mistimed clock, not a restless mind — which is why it helps jet lag more than ordinary insomnia.

Professional guidelines land in the same place. The American Academy of Sleep Medicine's pharmacologic guideline suggested against using melatonin for chronic insomnia, because the evidence base was too weak to support it 2Ref 2Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017).Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.AASM pharmacologic guideline suggests against using melatonin for chronic insomnia because of insufficient evidence, supporting the guideline-not-recommended framing for melatonin in ordinary insomnia.. That is not a claim that melatonin is dangerous or useless. It is a precise statement that, for the most common form of insomnia, the controlled trials do not show it works well enough to be a treatment.

Melatonin is a clock signal, not a sedative

The single most useful thing to understand about melatonin is that it is not a knockout drug. It is a hormone the brain releases as darkness falls, and its job is to tell the body's internal clock that night has begun. It nudges the timing of sleep; it does not force sleep the way a sedative does. That is why a person can take it and still lie awake — the signal says "it is night," but it does nothing to quiet a racing mind or an over-aroused nervous system.

Melatonin is a circadian hormone that signals biological night; it sets sleep timing rather than sedating the brain.

This mechanism explains the whole pattern of the evidence. Because melatonin works on timing, its effect depends far more on when it is taken than on how much — melatonin timing is the lever that matters, and taking it at the wrong hour can even push the clock the wrong way. It also explains why melatonin shines for problems that are genuinely about timing and disappoints for problems that are not. Everything else on this page follows from that one distinction.

Where melatonin genuinely helps: circadian problems

Melatonin earns its place in the toolkit for circadian rhythm problems — the situations where the body clock is out of step with the desired sleep schedule. The clearest is jet lag, where a fast time-zone change leaves the internal clock hours behind or ahead. A national health-agency review credits melatonin with a real role there, and in delayed sleep-wake phase disorder, the pattern common in night owls whose clock runs hours late 1Ref 1National Center for Complementary and Integrative Health (2022).Melatonin: What You Need To Know.NCCIH evidence summary: melatonin has a role in jet lag and delayed sleep-wake phase disorder and may modestly shorten sleep-onset latency, but per AASM and ACP there is not enough strong evidence to recommend it for chronic insomnia — supporting both the circadian-role and weak-for-insomnia claims..

The direction of a schedule shift matters, too. Traveling east, which asks the clock to move earlier, is generally the harder adjustment, and it is a common setting for a properly timed dose; the underlying rule is always that the timing relative to the body's own rhythm is what does the work. In delayed sleep-wake phase disorder, the same principle applies to a clock that is chronically set late rather than to a one-off trip.

Shift work is the messier cousin of these. When someone must sleep during the day and work at night, their clock and their schedule are permanently at odds, and melatonin for shift work is sometimes used to help anchor daytime sleep — though the evidence there is more mixed than for jet lag, and it is covered on its own page. What unites all of these is that the problem is timing, not an inability to fall asleep once the clock and the schedule agree. That is the narrow, legitimate lane where melatonin does what it is designed to do.

Where the evidence is weak: chronic insomnia

Chronic insomnia is a different animal, and it is where melatonin's reputation outruns its results. Most chronic insomnia is not a clock problem — it is driven by hyperarousal and by learned associations that turn the bed into a cue for wakefulness. A signal that says "it is night" does little against a nervous system that is already convinced bedtime means lying awake. The evidence reflects this: reviews find, at best, a small effect on sleep onset and no reliable benefit for staying asleep 1Ref 1National Center for Complementary and Integrative Health (2022).Melatonin: What You Need To Know.NCCIH evidence summary: melatonin has a role in jet lag and delayed sleep-wake phase disorder and may modestly shorten sleep-onset latency, but per AASM and ACP there is not enough strong evidence to recommend it for chronic insomnia — supporting both the circadian-role and weak-for-insomnia claims..

That is why the guideline suggestion runs against melatonin for this use 2Ref 2Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017).Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.AASM pharmacologic guideline suggests against using melatonin for chronic insomnia because of insufficient evidence, supporting the guideline-not-recommended framing for melatonin in ordinary insomnia.. The risk is not usually harm from the melatonin itself; it is the months a person can spend cycling through supplements while the actual insomnia goes untreated. Melatonin is the reasonable-sounding first thing almost everyone reaches for, and for the most common insomnia it is aimed at the wrong mechanism. Recognizing that early is what points a person toward a treatment that fits the problem.

Timing, and what is actually in the bottle

Two practical issues shape whether melatonin does anything at all, and neither is about taking more of it. The first is timing. Because melatonin sets the clock rather than sedating the brain, the hour it is taken relative to a person's own rhythm matters more than the amount — the same product can help or do nothing depending on when it is used, which is why melatonin timing has its own page. This is also why more is not better and why no dose is named here.

The second is the product itself. Because supplements are regulated as foods rather than medicines, the amount and purity in a bottle can vary from what the label claims, and what's actually in melatonin supplements has been a recurring quality concern — a reason to treat the number on the box with some skepticism. There is also a prescription cousin worth knowing about: ramelteon is a medicine that acts on the same melatonin receptors and is prescribed specifically for trouble falling asleep, a regulated alternative to the over-the-counter supplement covered on its own page. The through-line is that melatonin is a precision tool for timing, not a dial you turn up for stronger sleep.

Reading the melatonin aisle

The supplement aisle sells melatonin in a confusing spread of strengths and formats, and the marketing tends to push exactly the wrong instinct. Products are labelled by amount and by 'extra strength,' which invites the assumption that a bigger number means better sleep. For a signal that works by timing rather than sedation, that framing is misleading: the amount on the box is not the lever that decides whether it helps, and more is not safer.

Format adds another layer. Immediate-release tablets, extended-release versions meant to cover the whole night, gummies, sprays, and liquids all behave a little differently, and gummies in particular are easy to over-consume because they taste like candy. None of these differences is a reason to chase a stronger product; they are reasons to be modest and deliberate. The two questions that genuinely change whether melatonin does anything — when it is taken relative to a person's own clock, and whether the bottle actually contains what the label claims — are about timing and manufacturing, not about picking the biggest number on the shelf.

Melatonin in older adults and children

Two groups come up most often with melatonin, and both call for extra care. Older adults are frequently the ones who try it, partly because the body's own melatonin output tends to decline with age. That does not make it a proven treatment for the insomnia that becomes more common later in life, which more often reflects a shifting body clock, medical conditions, and medications than a simple melatonin shortage — and, notably, the insomnia treatment with the most durable evidence in older adults is behavioral rather than any pill.

Children are the other group, and here the caution is sharper. Melatonin use in children has climbed quickly, and so have reports of accidental ingestion from candy-like gummies left within a child's reach — which is why child-resistant storage matters and why melatonin for a child is a conversation to have with a pediatrician rather than a default choice. Pregnancy and breastfeeding are further situations where the sensible step is to ask a clinician first. The common thread is that melatonin is easy to buy and easy to over-rely on, and the people most likely to reach for it are often the very ones for whom the underlying sleep problem deserves a closer look.

What actually works for chronic insomnia

If melatonin is aimed at the wrong mechanism for chronic insomnia, the natural question is what is aimed at the right one. The answer, with the strongest evidence behind it, is cognitive behavioral therapy for insomnia — a structured, non-drug program that targets the hyperarousal and learned associations at the root of the problem. A meta-analysis of many randomized trials found it produces clinically meaningful improvements in falling and staying asleep, with effects that last after treatment ends 3Ref 3Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D (2015).Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis.Meta-analysis of randomized trials finding CBT-I produces clinically meaningful improvements in sleep-onset latency, wake after sleep onset, and sleep efficiency with durable effects, supporting CBT-I as the evidence-backed treatment contrasted with melatonin.. What the program actually does is concrete rather than mysterious: it rebuilds the association between the bed and sleep, retimes and consolidates time in bed, and works on the anxious, effortful thinking that keeps an aroused mind awake — the very mechanism a body-clock signal leaves untouched.

It also outperforms sleeping pills where the two have been compared head to head. In a randomized trial in older adults, cognitive behavioral therapy beat the sleeping pill zopiclone on objective sleep measures, and its gains held at follow-up while the pill's did not 4Ref 4Sivertsen B, Omvik S, Pallesen S, et al. (2006).Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial.RCT in older adults finding CBT-I outperformed the z-drug zopiclone on polysomnographic sleep measures with gains holding at follow-up, while zopiclone was no better than placebo long-term — supporting that a behavioral treatment beats a sleeping pill for durable results.. Sleep-medicine guidelines put this behavioral approach first for chronic insomnia on the strength of formal evidence grading 5Ref 5Edinger JD, Arnedt JT, Bertisch SM, et al. (2021).Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.AASM systematic review with GRADE quantifying the effects of behavioral treatments for chronic insomnia, supporting that guidelines place CBT-I first on formally graded evidence., and it no longer requires an office visit: a large randomized trial of digital cbt-i found it improved sleep and daytime well-being through an app 6Ref 6Espie CA, Emsley R, Kyle SD, et al. (2019).Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial.Large RCT of digital CBT-I finding improvements in sleep and daytime well-being delivered via an app, supporting that the evidence-backed alternative to melatonin is available in accessible digital form.. For anyone weighing melatonin against another supplement — valerian for sleep, say — the more useful comparison is not between two weak supplements, but between a supplement and the treatment the evidence actually supports.